| Medicare WPS | Billing and Coding: MolDX: Breast Cancer Index® (BCI) Gene Expression Test (56335) | 2025-04-25 |
| Medicare WPS | Billing and Coding: MolDX: Breast Cancer Assay: Prosigna® (57560) | 2025-04-25 |
| Medicare WPS | Billing and Coding: MolDX: EndoPredict® Breast Cancer Gene Expression Test (57567) | 2025-04-25 |
| Medicare WPS | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (59004) | 2025-04-25 |
| BCBS Highmark Penn Medicare Advantage | Genetic Testing in Oncology: Specific Tests | 2025-04-24 |
| BCBS Highmark Penn Medicare Advantage | Biomarkers for Oncology | 2025-04-24 |
| Meridian Illinois Medicaid Clinical | Darbepoetin Alfa | 2025-04-24 |
| Meridian Illinois Medicaid Clinical | Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) | 2025-04-24 |
| Medicare WPS | Billing and Coding: Erythropoiesis Stimulating Agents (ESAs) (56795) | 2025-04-23 |
| Aetna | Mogamulizumab-kpkc (Poteligeo) | 2025-04-21 |